Tabituximab Biosimilar - Anti-FZD10 Antibody - BSA and Azide free
Descrizione
Recombinant chimeric monoclonal antibody to FZD10.
Applicazioni
ELISA, Flow Cytometry
Diluizioni consigliate
ELISA: 1:5,000-10,000, Flow Cytometry: 1:100
Reattività
Human
Specie ospite
Chimeric
Clonalità
Monoclonal
Isotipo
IgG1
Coniugare
Unconjugated
Purificazione
Affinity chromatography.
Concentrazione
Reconstitution dependent.
Forma del prodotto
Lyophilized
Ricostituzione
Reconstitute with distilled sterile water.
Formulazione
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization.
Conservazione
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Note generali
Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.
ELISA plates were pre-coated with Recombinant Human FZD10 Protein (Fc Tag) (A318093) at 2 µg/ml (100 µl/well) which can bind Tabituximab Biosimilar - Anti-FZD10 Antibody - BSA and Azide free (A324693) in a linear range of 3.20-80 ng/ml.In order to specifically detect Tabituximab Biosimilar - Anti-FZD10 Antibody - BSA and Azide free (A324693), Mouse Anti-Human Fab Antibody was used as detection antibody.
Flow cytometry analysis of 1µg/ml of Tabituximab Biosimilar - Anti-FZD10 Antibody - BSA and Azide free (A324693) on Expi293 cells transfected with Human FZD10 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).
Prodotti alternativi a Anti-FZD10 Anticorpo (A324693)